hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06382623, orgStudyIdInfo id: 43, briefTitle: Efficacies of Different Managements in Patients With Trigger Finger, statusModule overallStatus: COMPLETED, startDateStruct date: 2022-10-01, primaryCompletionDateStruct date: 2023-06-30, completionDateStruct date: 2023-06-30, studyFirstPostDateStruct date: 2024-04-24, lastUpdatePostDateStruct date: 2024-04-24, sponsorCollaboratorsModule leadSponsor name: Gaziler Physical Medicine and Rehabilitation Education and Research Hospital, class: OTHER, descriptionModule briefSummary: The aim of the study is to compare the effectiveness of peritendinous steroid injection under ultrasound guidance and percutaneous A1 pulley release procedures in terms of disease stage, pain, and severity of locking in patients with trigger finger., conditionsModule conditions: Trigger Finger, designModule studyType: OBSERVATIONAL, designInfo observationalModel: OTHER, timePerspective: PROSPECTIVE, enrollmentInfo count: 30, type: ACTUAL, armsInterventionsModule interventions name: The percutaneous A1 pulley release, interventions name: The peritendinous Betamethasone group, outcomesModule primaryOutcomes measure: Stage of the disease, secondaryOutcomes measure: Pain intensity, secondaryOutcomes measure: severity of triggering, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Ankara Gaziler Physical Medicine and Rehabilitation Education and Research Hospital, city: Ankara, country: Turkey, geoPoint lat: 39.91987, lon: 32.85427, hasResults: False
protocolSection identificationModule nctId: NCT06382610, orgStudyIdInfo id: 2024-002, briefTitle: Pharmacokinetics of Melatonin Administered in Oral, Lotion, and Bubble Bath Formulations, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-05-10, primaryCompletionDateStruct date: 2024-12-15, completionDateStruct date: 2024-12-15, studyFirstPostDateStruct date: 2024-04-24, lastUpdatePostDateStruct date: 2024-04-24, sponsorCollaboratorsModule leadSponsor name: University of Redlands, class: OTHER, descriptionModule briefSummary: Melatonin is a hormone that promotes sleep that is available without a prescription in the United States. In addition to oral supplements, melatonin can be purchased in the form of lotions and bubble baths with unknown dosage and no frequency or age recommendations. In this study, researchers will examine how quickly melatonin in lotion and bubble bath is absorbed compared to oral tablets, as well as how long the melatonin lasts in the body., conditionsModule conditions: Sleep, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: CROSSOVER, interventionModelDescription: Repeated measures crossover trial, primaryPurpose: BASIC_SCIENCE, maskingInfo masking: NONE, enrollmentInfo count: 10, type: ESTIMATED, armsInterventionsModule interventions name: Melatonin, outcomesModule primaryOutcomes measure: Salivary melatonin level, secondaryOutcomes measure: Side effects, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 22 Years, stdAges: ADULT, contactsLocationsModule locations facility: University of Redlands, city: Redlands, state: California, zip: 92373, country: United States, geoPoint lat: 34.05557, lon: -117.18254, hasResults: False
protocolSection identificationModule nctId: NCT06382597, orgStudyIdInfo id: AWFiS/2024_2_P-GM, briefTitle: Four Weeks of Nordic Hamstring Exercises Impact the Strength and Balance of the Hamstring Muscle Group, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-05-01, primaryCompletionDateStruct date: 2024-07-10, completionDateStruct date: 2024-07-10, studyFirstPostDateStruct date: 2024-04-24, lastUpdatePostDateStruct date: 2024-04-24, sponsorCollaboratorsModule leadSponsor name: Gdansk University of Physical Education and Sport, class: OTHER, descriptionModule briefSummary: The aim of the study is to assess the impact of 4 weeks of eccentric Nordic Hamstring Exercise training on changes in the hamstring muscle group, as well as to analyze parameters such as maximum muscle strength of the knee flexors, RFD (rate of force development) and static balance, dynamics for the dominant leg., conditionsModule conditions: Hamstring Injury, designModule studyType: OBSERVATIONAL, designInfo observationalModel: OTHER, timePerspective: OTHER, enrollmentInfo count: 2, type: ESTIMATED, armsInterventionsModule interventions name: Nordic hamstring exercise, outcomesModule primaryOutcomes measure: Biodex Balance System, secondaryOutcomes measure: Biodex System, eligibilityModule sex: ALL, minimumAge: 19 Years, maximumAge: 26 Years, stdAges: ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06382584, orgStudyIdInfo id: IRB_23.09.01, briefTitle: Impact of Treatment With Oral Anticoagulants of Patients With Fractures of the Upper End of the Femur, acronym: ANTI_XA, statusModule overallStatus: COMPLETED, startDateStruct date: 2022-01-01, primaryCompletionDateStruct date: 2023-06-01, completionDateStruct date: 2023-06-01, studyFirstPostDateStruct date: 2024-04-24, lastUpdatePostDateStruct date: 2024-04-24, sponsorCollaboratorsModule leadSponsor name: Centre Hospitalier Universitaire de Nīmes, class: OTHER, descriptionModule briefSummary: In 2023, oral anticoagulant treatments (anti Xa: apixaban, rivaroxaban, etc.) are tending to replace anti vitamin K treatments in many medical indications. Their prescription is increasing rapidly in the elderly.In this context, the Nimes University Hospital receives a large number of elderly patients who have suffered a fracture of the end of the femur requiring surgery and who are taking anti Xa drugs.To avoid massive intra- and post-operative haemorrhage, surgical management is postponed because of the need to suspend the treatment, allowing a return to near-normal biological haemostasis within a few days. No consensus has been reached on the withdrawal period required to authorise surgery, as the elimination kinetics of the drug are altered in this context (elderly patients, dehydration, hypovolaemia, impaired renal function). A plasma assay (threshold of \<30 to 60 ng/mL) has been proposed without any real justification. This waiting period exposes the elderly to excess mortality. Reversing these treatments by adding coagulation factors would be an attractive alternative, as it would allow surgery to be performed earlier, but this would expose patients to an increased thrombotic risk.Before considering a prospective randomised study (early vs delayed surgery on AOD), we wish to retrospectively analyse data on patients admitted to the Nimes University Hospital on anti Xa and operated on for fracture of the upper end of the femur between 1 January 2022 and 1 June 2023, conditionsModule conditions: Direct Oral Anticoagulants (DOACs), conditions: Femoral Fractures, conditions: Surgery, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: RETROSPECTIVE, enrollmentInfo count: 610, type: ACTUAL, armsInterventionsModule interventions name: Femoral fracture surgery, outcomesModule primaryOutcomes measure: Hospital Mortality, secondaryOutcomes measure: Duration of the surgery, secondaryOutcomes measure: Transfusion, secondaryOutcomes measure: Postoperative comorbidities, secondaryOutcomes measure: Hospital stay, secondaryOutcomes measure: Anti Xa assay, eligibilityModule sex: ALL, minimumAge: 65 Years, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: CHU de NIMES, city: Nimes, zip: 30029, country: France, geoPoint lat: 43.83333, lon: 4.35, hasResults: False
protocolSection identificationModule nctId: NCT06382571, orgStudyIdInfo id: 026/66, briefTitle: Factors Associated With Sub - Targeted Therapeutic Dose Of Renin - Angiotensin Blockage Among Chronic Heart Failure With Reduced Ejection Fraction Patients, statusModule overallStatus: COMPLETED, startDateStruct date: 2016-01-01, primaryCompletionDateStruct date: 2020-12-31, completionDateStruct date: 2021-12-31, studyFirstPostDateStruct date: 2024-04-24, lastUpdatePostDateStruct date: 2024-04-24, sponsorCollaboratorsModule leadSponsor name: Chulalongkorn University, class: OTHER, descriptionModule briefSummary: Objective: To analyze factors associated with Thai heart failure with reduced ejection fraction patients who received sub-target doses of Angiotensin converting enzyme inhibitors (ACEIs), angiotensin receptor-neprilysin inhibitors (ARNIs), and angiotensin receptor blockers (ARBs).Methods: The retrospective cohort study was designed to collect data on Thai heart failure with reduced ejection fraction patients at Out-patient Clinic, Trat Hospital and Phrapokklao Hospital from January 2016 to December 2020. Thirteen factors were analyzed to determine their association with the sub-target group., conditionsModule conditions: Heart Failure With Reduced Ejection Fraction, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: RETROSPECTIVE, enrollmentInfo count: 396, type: ACTUAL, armsInterventionsModule interventions name: Renin-Angiotensin System Inhibitor, outcomesModule primaryOutcomes measure: factors associated with sub - target dose of ACEIs,ARBs,ARNI, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, hasResults: False
protocolSection identificationModule nctId: NCT06382558, orgStudyIdInfo id: s68470, secondaryIdInfos id: C2M/23/060, type: OTHER_GRANT, domain: KU Leuven, briefTitle: Validity and Reliability of Sensorimotor Processing Paradigm, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-04-10, primaryCompletionDateStruct date: 2024-12-31, completionDateStruct date: 2024-12-31, studyFirstPostDateStruct date: 2024-04-24, lastUpdatePostDateStruct date: 2024-04-24, sponsorCollaboratorsModule leadSponsor name: KU Leuven, class: OTHER, descriptionModule briefSummary: Sensorimotor function of the upper limb is often impaired after stroke, even in the chronic phase (minimum 6 months after stroke). Currently, an optimal assessment for sensory processing, one of the most important sensory functions, does not exists. However, our research team has developed a novel assessment paradigm using the KINARM End-Point robot to assess the level of sensory processing of the upper limb. Within a previous study, the investigators examined the validity within 20 chronic stroke patients and 80 age-matched healthy controls by comparing the novel robotic assessment with a set of existing clinical and robotic assessments for the upper limb. The investigators hypothesize that the stroke patients will show a poorer performance on this novel assessment compared to the healthy controls, that the novel assessment will show better correlation coefficients with other sensory tests compared to motor tests, that the novel assessment can differentiate between different motor subgroups of chronic stroke patients, and that the novel assessment shows good test-retest reliability., conditionsModule conditions: Stroke, designModule studyType: OBSERVATIONAL, designInfo observationalModel: CASE_CONTROL, timePerspective: CROSS_SECTIONAL, enrollmentInfo count: 60, type: ESTIMATED, armsInterventionsModule, outcomesModule primaryOutcomes measure: Kinarm: Passive and active discrimination task, secondaryOutcomes measure: Kinarm: Arm position matching task, secondaryOutcomes measure: Kinarm: Visually guided reaching task, secondaryOutcomes measure: Erasmus modified Nottingham sensory assessment, secondaryOutcomes measure: Tactile discrimination test, secondaryOutcomes measure: Tactile functional object recognition, secondaryOutcomes measure: Stereognosis section of the original Nottingham sensory assessment, secondaryOutcomes measure: Wrist position sense test, secondaryOutcomes measure: Perceptual threshold of touch, secondaryOutcomes measure: Fugl-Meyer upper extremity assessment, secondaryOutcomes measure: Action research arm test, secondaryOutcomes measure: Barthel index, secondaryOutcomes measure: Montreal cognitive assessment, secondaryOutcomes measure: Star cancellation test, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: KU Leuven, status: RECRUITING, city: Leuven, zip: 3001, country: Belgium, contacts name: Geert Verheyden, Prof. Dr., role: CONTACT, geoPoint lat: 50.87959, lon: 4.70093, hasResults: False
protocolSection identificationModule nctId: NCT06382545, orgStudyIdInfo id: Approval number 36.3.22, briefTitle: Post-instrumentation Pain After Use of the Fanta and M3 Pro Gold Systems, statusModule overallStatus: COMPLETED, startDateStruct date: 2021-11-01, primaryCompletionDateStruct date: 2022-06-30, completionDateStruct date: 2022-07-30, studyFirstPostDateStruct date: 2024-04-24, lastUpdatePostDateStruct date: 2024-04-24, sponsorCollaboratorsModule leadSponsor name: Ahram Canadian University, class: OTHER, descriptionModule briefSummary: Comparing the intensity of post-operative pain following endodontic treatment of posterior teeth with Fanta (Pepsi gold) (FPG) and M3-pro+ Gold (assorted) (MPG) rotary files., conditionsModule conditions: Endodontic Treatment, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: SINGLE, whoMasked: PARTICIPANT, enrollmentInfo count: 40, type: ACTUAL, armsInterventionsModule interventions name: Fanta (Pepsi gold) (FPG), interventions name: M3-pro+ Gold (assorted) (MPG), outcomesModule primaryOutcomes measure: comparing the intensity of post-instrumentation pain, eligibilityModule sex: ALL, minimumAge: 20 Years, maximumAge: 50 Years, stdAges: ADULT, contactsLocationsModule locations facility: Faculty of Oral and Dental medicine, Ahram Canadian University, city: Giza, zip: 12573, country: Egypt, geoPoint lat: 30.00808, lon: 31.21093, hasResults: False
protocolSection identificationModule nctId: NCT06382532, orgStudyIdInfo id: AFMMUChina_NSRT, briefTitle: Diagnosis of Depressive Disorder Malinger Using the Niacin Skin Response Test (NSRT), statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-05-01, primaryCompletionDateStruct date: 2026-05-01, completionDateStruct date: 2026-05-01, studyFirstPostDateStruct date: 2024-04-24, lastUpdatePostDateStruct date: 2024-04-24, sponsorCollaboratorsModule leadSponsor name: Air Force Military Medical University, China, class: OTHER, descriptionModule briefSummary: This study will explore the specific response characteristics of the niacin skin response test in the population with depressive disorder malinger. The investigators expect that depressive disorder malinger can be discriminated by the niacin skin reaction test., conditionsModule conditions: Depressive Disorder, conditions: Malingering, designModule studyType: OBSERVATIONAL, designInfo observationalModel: CASE_CONTROL, timePerspective: CROSS_SECTIONAL, enrollmentInfo count: 410, type: ESTIMATED, armsInterventionsModule interventions name: Niacin skin reaction test, outcomesModule primaryOutcomes measure: Niacin reaction test, secondaryOutcomes measure: Model specificity and sensitivity, secondaryOutcomes measure: The F Scale in Minnesota Multiphasic Personality Inventory, eligibilityModule sex: MALE, minimumAge: 18 Years, maximumAge: 60 Years, stdAges: ADULT, contactsLocationsModule locations facility: Air Force Medical Center, city: Beijing, state: Beijing, zip: 100142, country: China, contacts name: Jin Wang, role: CONTACT, geoPoint lat: 39.9075, lon: 116.39723, hasResults: False
protocolSection identificationModule nctId: NCT06382519, orgStudyIdInfo id: Thal in VEOIBD, briefTitle: Thalidomide Therapy for VEOIBD, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-05-15, primaryCompletionDateStruct date: 2025-12-31, completionDateStruct date: 2026-12-31, studyFirstPostDateStruct date: 2024-04-24, lastUpdatePostDateStruct date: 2024-04-24, sponsorCollaboratorsModule leadSponsor name: Children's Hospital of Fudan University, class: OTHER, descriptionModule briefSummary: This is a single center, observational study to investigate the clinical outcomes of thalidomide treatment for very early onset inflammatory bowel disease, conditionsModule conditions: Inflammatory Bowel Diseases, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 40, type: ESTIMATED, armsInterventionsModule interventions name: Thalidomide, outcomesModule primaryOutcomes measure: endoscopic response rate, secondaryOutcomes measure: clinical response rate, secondaryOutcomes measure: biomarker remission rate, secondaryOutcomes measure: growth development, secondaryOutcomes measure: clinical remission rate with steroid-free, secondaryOutcomes measure: adverse event, secondaryOutcomes measure: treatment persistence, eligibilityModule sex: ALL, minimumAge: 28 Days, maximumAge: 6 Years, stdAges: CHILD, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06382506, orgStudyIdInfo id: 2024/138, briefTitle: The Effect of Hazelnut Flour on Blood Glucose, acronym: Hazelnut, statusModule overallStatus: COMPLETED, startDateStruct date: 2024-03-21, primaryCompletionDateStruct date: 2024-04-21, completionDateStruct date: 2024-04-21, studyFirstPostDateStruct date: 2024-04-24, lastUpdatePostDateStruct date: 2024-04-24, sponsorCollaboratorsModule leadSponsor name: Ege University, class: OTHER, descriptionModule briefSummary: One of the factors affecting human health is nutrition. The effects of foods on blood glucose are still under investigation. The Glycemic Index (GI), which is associated with many diseases today, is a value that measures the rate at which carbohydrate-containing foods raise blood glucose. It is thought that the loaves of bread produced will be a product with low GI value and can be consumed by celiacs and diabetics. It is aimed to investigate the effect of adding different amounts of hazelnut flour to bread recipes using gluten-free corn flour on blood glucose., conditionsModule conditions: Obesity, conditions: Celiac Disease, conditions: Blood Glucose, conditions: Flour Sensitivity, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: SUPPORTIVE_CARE, maskingInfo masking: SINGLE, whoMasked: PARTICIPANT, enrollmentInfo count: 24, type: ACTUAL, armsInterventionsModule interventions name: Consumption of Cornbread with Hazelnut Bread, outcomesModule primaryOutcomes measure: One loaf of bread was consumed each week and the study will continue for a month. Blood glucose measurements were performed with a glucometer at 0 (fasting), 15, 30, 45, 60, 90, and 120 minutes after each bread consumption., secondaryOutcomes measure: This classification as obese and normal-weight individuals was made with the BIA (Bioelectrical impedance analysis) method. This classification was understood by anthropometric measurements made in the first week., eligibilityModule sex: FEMALE, minimumAge: 18 Years, maximumAge: 30 Years, stdAges: ADULT, contactsLocationsModule locations facility: Avrasya University, city: Trabzon, zip: 61000, country: Turkey, geoPoint lat: 41.005, lon: 39.72694, hasResults: False
protocolSection identificationModule nctId: NCT06382493, orgStudyIdInfo id: B-2011-648-005, briefTitle: Tegoprazan-containing Sequential for H. Pylori, statusModule overallStatus: RECRUITING, startDateStruct date: 2021-02-01, primaryCompletionDateStruct date: 2024-12-12, completionDateStruct date: 2024-12-12, studyFirstPostDateStruct date: 2024-04-24, lastUpdatePostDateStruct date: 2024-04-24, sponsorCollaboratorsModule leadSponsor name: Seoul National University Bundang Hospital, class: OTHER, descriptionModule briefSummary: As H. pylori eradication, we prepared a randomized controlled clinical trial whether tegoprazan-containing 10-day sequential treatment was effective compared to conventional PPI-containing 10-day sequential eradication therapy, conditionsModule conditions: Helicobacter Pylori Infection, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 400, type: ESTIMATED, armsInterventionsModule interventions name: Tegoprazan-containing sequential H. pylori eradication therapy, outcomesModule primaryOutcomes measure: Eradication rate, secondaryOutcomes measure: Adverse events, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Seoul National University Bundang Hospital, status: RECRUITING, city: Seongnam-si, state: Gyeonggi-do, zip: 463-707, country: Korea, Republic of, contacts name: Nayoung Kim, M.D.,Ph.D., role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 37.43861, lon: 127.13778, hasResults: False
protocolSection identificationModule nctId: NCT06382467, orgStudyIdInfo id: 2401-136-016, briefTitle: Comparison of Remimazolam and Propofol Combination vs. Propofol in IOM, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-05, primaryCompletionDateStruct date: 2025-05, completionDateStruct date: 2025-06, studyFirstPostDateStruct date: 2024-04-24, lastUpdatePostDateStruct date: 2024-04-24, sponsorCollaboratorsModule leadSponsor name: Chung-Ang University Gwangmyeong Hospital, class: OTHER, descriptionModule briefSummary: This study aims to compare total intravenous anesthetic agents: combined remimazolam and propofol vs. propofol monotherapy. The comparison parameters are intraoperative hypotension, patient's involuntary movement, neurophysiological monitoring quality, onset time, recovery time, and postoperative rescue anti-emetics requirements., conditionsModule conditions: Neurologic Disorder, designModule studyType: INTERVENTIONAL, phases: PHASE4, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: DOUBLE, whoMasked: PARTICIPANT, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 56, type: ESTIMATED, armsInterventionsModule interventions name: Remimazolam besylate + propofol MCT, interventions name: Propofol MCT, outcomesModule primaryOutcomes measure: Incidence of intraoperative hypotension, secondaryOutcomes measure: Amount and number of inotropic agents, secondaryOutcomes measure: Incidence of participants' intraoperative involuntary movement, secondaryOutcomes measure: scores of neurophysiologic monitoring quality, secondaryOutcomes measure: onset time of study drugs, secondaryOutcomes measure: The administration number of rescue anti-emetic agents, secondaryOutcomes measure: Time-weighted average of intraoperative hypotension, secondaryOutcomes measure: recovery time of study drugs (remimazolam+propofol or propofol), eligibilityModule sex: ALL, minimumAge: 19 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False